Home > Healthcare > Healthcare IT > Payer/Provider Solutions > predictive disease analytics market
Get a free sample of Predictive Disease Analytics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Predictive Disease Analytics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Several emerging trends are shaping the predictive disease analytics industry. One significant trend is the increasing adoption of cloud-based solutions. Cloud deployment offers scalability, flexibility, and cost-effectiveness, allowing healthcare organizations to handle large volumes of data and access analytics tools remotely. This shift to the cloud is enhancing data integration and real-time analysis capabilities.
Anaconda Inc., Allscripts Healthcare Solutions Inc., Apixio Inc., Epic System Corporation, Health Catalyst, IBM, McKesson Corporation, and MedeAnalytics, Inc.
North America predictive disease analytics industry size is anticipated to grow at 20.9% CAGR between 2024 and 2032 driven by the increasing emphasis on value-based healthcare and cost containment.
The predictive disease analytics industry was valued at USD 2.5 billion in 2023 and is expected to exhibit 21.7% CAGR from 2024 to 2032 attributed to increasing focus on streamlining of healthcare processes, and extensive advancements in AI and machine learning technologies.
The healthcare payers end-use segment in the market is anticipated to reach USD 9.6 billion by 2032 due to the increasing emphasis on cost control and risk management in the payer sector.